Article
08 Jun 2026
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
AUTHORS CONTENT
Article
06 Apr 2026
SEP Licensing In Europe: Recent Developments
Article
09 Jan 2026
UPC's Court Of Appeal Overturns First Instance Decision In Amgen V. Sanofi And Regeneron
Article
01 Dec 2025
Legal Landscapes: Germany – Patent Litigation
Article
09 Jan 2025
4 Key Takeaways For Litigants Filing UPC Revocation Actions
Guide
16 Oct 2024
Patent Litigation Comparative Guide
Guide
08 Oct 2024
Patent Litigation Comparative Guide
Article
30 Sep 2024
Navigating IP Challenges In The Wearable Tech Space
Article
22 Jul 2024
Artificial Intelligence And Patent Applications
Article
17 Jul 2024
Standard Essential Patents In The Unified Patent Court
Article
27 Jun 2024
The Unified Patent Court: What We Learned In Year 1
Article
14 Jun 2024
Regulation And Legislation In The Era Of Automation And Digitalisation
Article
01 May 2024
Injunctive Relief For Standard Essential Patents In International Jurisdictions
Article
19 Apr 2024
UPC's Court Of Appeal Paves The Way For More Transparency
Article
24 Aug 2023
Unified Patent Court Offers Far-Reaching Opportunities For MedTech Companies
Article
17 Aug 2023
UPC: The ‘Sharp Sword' Of Global Patent Litigation
Article
09 Aug 2023
First UPC Preliminary Injunction Issued Ex Parte Despite Protective Brief
Article
06 Jul 2023
Third Central Division Of The Unified Patent Court To Be Established In Milan
Article
31 May 2023
Unified Patent Court: Continued Preparations For Its Imminent Launch
Article
26 May 2023
UPC: "Human Necessities" Heard In Paris, "Chemistry And Metallurgy" In Munich Central Division